Impact of iron deficiency on long-term clinical outcomes of hospitalized patients with heart failure
Hiroki Nakano(Honda (Japan)), Toshihisa Anzai(Hokkaido University), Satoshi Yasuda(Tohoku University), Takeshi Aiba(National Cerebral and Cardiovascular Center), Taishiro Chikamori(Tokyo Medical University), Hisao Ogawa(Kumamoto University Hospital), Satoshi Honda(National Cerebral and Cardiovascular Center), Yasuyuki Honda(National Cerebral and Cardiovascular Center), Toshiyuki Nagai(Hokkaido University), Kunihiro Nishimura(National Cerebral and Cardiovascular Center), Teruo Noguchi(National Cerebral and Cardiovascular Center), Yasuhide Asaumi(National Cerebral and Cardiovascular Center), Kengo Kusano(Northwestern University), Michikazu Nakai(National Cerebral and Cardiovascular Center), Naotsugu Iwakami(Kyoto University), Yasuo Sugano(keiyu Hospital), Hiroyuki Yokoyama(Honda (Japan)), Varun Sundaram(University Hospitals of Cleveland)
Cited by 28
Related Papers
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
|New England Journal of Medicine|2017|9.1k
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
|Circulation|1994|1.3k
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
|The Lancet|2017|1.3k
Thrombin-Receptor Antagonist Vorapaxar in Acute Coronary Syndromes
|New England Journal of Medicine|2011|755